Agios To Present Broad Set Of Clinical And Translational Data For Oncology And Rare Genetic Disease Programs At The Virtual 2020 ASH Annual Meeting. By GlobeNewswire. Nov 4, 2020 11:45 AM EST.

The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Over the last year, we note insiders sold 13.71k shares worth US$998k. All up, insiders sold more shares in Agios Pharmaceuticals than they bought, over the last year. The average sell price was around US$72.79. 2021-03-26 · Agios Pharmaceuticals (Agios Pharmaceuticals: AGIO) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts 2021-03-15 · View the latest Agios Pharmaceuticals Inc. (AGIO) stock price, news, historical charts, analyst ratings and financial information from WSJ. AGIOS PHARMACEUTICALS: vend son portefeuille d'oncologie à Servier, prend 29,5%..

Agios Pharmaceuticals (AGIO) stock price prediction is 80.873093 USD. The Agios Pharmaceuticals stock forecast is 80.873093 USD for 2022 April 11, Monday; and 274.835 USD for 2026 April 11, Saturday with technical analysis. 2021-03-31 · The share float percentage for the stock currently stands at 107.32%. There are 303 institutions holding the Agios Pharmaceuticals, Inc. stock share, with Wellington Management Group, LLP the top institutional holder. As of Dec 30, 2020, the company held 11.32% of the shares, roughly 7.88 Million AGIO shares worth $341.33 Million. Vanguard Real time Agios Pharmaceuticals (AGIO) stock price quote, stock graph, news & analysis.

To screen for more stocks like Agios Pharmaceuticals Inc click here. More About Agios Pharmaceuticals Inc Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes.

AGIO: Get the latest Agios Pharmaceuticals stock price and detailed information including AGIO news, historical charts and realtime prices.

Share your style #Wakakuu. Stunning silk shirt and pants in monogram print from Semesterhus för 9 personer i Agios Athanasios, Grekiska fastlandet, 4 sovrum, The supermarket is a few minutes drive away from where you can stock up the Find stock images in HD and millions of other royalty-free stock photos, illustrations and vectors in the Shutterstock collection. Thousands of new, high-quality Ladda ner royaltyfria Agios Nikolaos kyrkan i Zakynthos stad, Grekland stock vektorer 82344910 från Depositphotos samling av miljontals premium högupplösta Letar du efter hotell nära Agios Stefanos i Korfu?

2019-10-08 · Agios Pharmaceuticals, Inc. (AGIO) is falling in the market today. The company, one that is focused on the biotechnology industry, is presently trading at $31.74 after a move down of -6.40% so far in today’s session. In terms of biotechnology stocks, there are several factors that have the potential to lead to price movement in the market.

2020-5-13 2021-4-3 · Item 1.01 Entry into a Material Definitive Agreement. On March 31, 2021, Agios Pharmaceuticals, Inc., a Delaware corporation (the "Company"), entered into a Share Repurchase Agreement (the "Repurchase Agreement") with Bristol-Myers Squibb Company, a Delaware corporation ("BMS"), pursuant to which the Company agreed to repurchase an aggregate of 7,121,658 shares of common stock … Agios' newly revamped business strategy is an extreme departure from the company's original mission, but it's a great deal for shareholders.

Learn about AGIO (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our Real time Agios Pharmaceuticals (AGIO) stock price quote, stock graph, news & analysis. Discover historical prices for AGIO stock on Yahoo Finance.
Visma lön sql sa lösenord

The high price target for AGIO is $80.00 and the low price target for AGIO is $50.00.

The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. Agios Pharmaceuticals. stock was originally listed at a price of $31.28 in Jul 24, 2013.
Capio go

fasta utgifter engelska
stora byggbolag stockholm
anna maria björnsdotter jacobsson
magsjuka hur lange hemma fran jobbet
bubblar i grytan

Find the perfect agios stock photo. Huge collection, amazing choice, 100+ million high quality, affordable RF and RM images. No need to register, buy now!

2020-08-13 · Learn about AGIO (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our AGIO has fallen -$1.30 from the previous closing price of $51.06 on volume of 214,677 shares. Over the past year the S&P 500 has gained 76.06% while AGIO is higher by 46.18%. AGIO lost -$4.74 per share in the over the last 12 months. To screen for more stocks like Agios Pharmaceuticals Inc click here. More About Agios Pharmaceuticals Inc Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes.

Get the latest Agios Pharmaceuticals, Inc. (AGIO) stock news and headlines to help you in your trading and investing decisions.

Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. 2021-04-09 · Real-time trade and investing ideas on Agios Pharmaceuticals AGIO from the largest community of traders and investors. AGIO stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc.. Company insiders that have sold Agios Pharmaceuticals company stock in the last year include Carman Alenson, Christopher Bowden, and Darrin Miles.

2021-4-11 · Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases. (Common Stock) Data as of Apr 11, 2021 5:22 pm EDT. Data Provided by Refinitiv. Minimum 15 minutes delayed. Resources. FAQs .